Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Top Stories

Top Stories

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General
  • Top Stories

Party Like It’s 1999: ’90s Fashion Is Making A Comeback — These Stocks Are Benefiting

By Aaron Bry
May 31, 9:32 AM
'90s fashion is making a comeback with help from social media and trendy endorsements. Companies like Abercrombie & Fitch and American Eagle are seeing strong sales, while experts suggest thrift shopping may also be on the rise.

AEO

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Top Stories

Gilead’s Trodelvy Fails To Hit Primary Goal In Late-Stage Study With Most Common Type Of Bladder Cancer

By Vandana Singh
May 31, 9:27 AM
Gilead Sciences' announced topline results from the Phase 3 TROPiCS-04 study on Trodelvy for metastatic urothelial cancer. The study did not meet the primary endpoint of overall survival but showed numerical improvements favoring Trodelvy.

GILD

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News
  • Top Stories

FDA Extends Review Deadline For Regeneron/Sanofi’s Dupixent For ‘Smoker’s Lungs’ Disease

By Vandana Singh
May 31, 9:23 AM
The FDA extends the target action date for reviewing Dupixent as an add-on treatment for uncontrolled COPD to September 27, 2024. This follows the submission of additional efficacy analyses from pivotal trials. European Medicines Agency also supports Dupixent for COPD.

REGN

Read More
2 minute read
  • Management
  • Movers
  • Tech
  • Top Stories
  • Trading Ideas

Faraday Future Stock Rebounds After 91% Crash In 8 Days; CEO Addresses ‘Misperceptions,’ Discusses ‘Overcoming Short Selling’

By Surbhi Jain
May 31, 9:02 AM
Faraday Future's stock rebounds 13.3% after 91% crash. CEO reassures investors about dilution & bankruptcy risks. Plans strategic update in 1-2 months.

FFIE

Read More
2 minute read
  • Top Stories

Apple, JPMorgan, Corning And More On CNBC’s ‘Final Trades’

By Avi Kapoor
May 31, 8:57 AM
On CNBC's "Halftime Report Final Trades," Stephanie Link of Hightower said Apple Inc. is still down 5% from its highs.

AAPL

Read More
1 minute read
  • Media
  • News
  • Tech
  • Top Stories

Alibaba and Coupang Intensify E-Commerce Battle with Major Investments in South Korea

By Anusuya Lahiri
May 31, 8:49 AM
Alibaba's AliExpress has doubled its users in South Korea to 8.58 million by investing $1.1 billion in a new logistics center, facing competition from Coupang and other Chinese e-commerce platforms.

AMZN

Read More
2 minute read
  • Top Stories

Jim Cramer: Beyond Meat Is ‘Way Too Risky,’ Warby Parker Is ‘Alright To Buy’

By Avi Kapoor
May 31, 8:47 AM
On CNBC's “Mad Money Lightning Round,” Jim Cramer said Warby Parker Inc. (NYSE:WRBY) is “alright to buy.“

AMD

Read More
3 minute read
  • General
  • Global
  • Markets
  • News
  • Politics
  • Tech
  • Top Stories

China’s ‘Decapitated’ Chip Sector Is Thrown $50B Lifeline

By Natan Ponieman
May 31, 8:44 AM
U.S.-China relations under Biden marked by efforts to block access to advanced chips. China investing $47.5B for self-reliance. Biden's measures aim for domestic production and block China's advances.

AMD

Read More
2 minute read
  • Bonds
  • Broad U.S. Equity ETFs
  • Econ #s
  • Economics
  • ETFs
  • Federal Reserve
  • Macro Economic Events
  • Macro Notification
  • Markets
  • Top Stories
  • Treasuries

Fed’s Preferred Inflation Gauge Matches Estimates; Personal Income, Spending Slow More Than Predicted

By Piero Cingari
May 31, 8:43 AM
The headline inflation rate held steady at 2.7% year-on-year in April 2024, matching economist expectations.

SPY

Read More
2 minute read
  • Media
  • News
  • Tech
  • Top Stories

OpenAI’s Apple Deal Sparks Concerns In Microsoft, Could Shift AI Market Dynamics

By Anusuya Lahiri
May 31, 8:22 AM
Microsoft concerned about potential Apple-OpenAI deal as it could impact its own AI ambitions. Altman aims to replace Google as Apple's search partner.

AAPL

Posts pagination

Previous 1 … 73 74 75 … 1,424 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service